A third dose of COVID‐19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant

• Takashi Toya,
• Daichi Sadato,
• Takahiro Sanada,
• Tomoko Honda,
• Yuya Atsuta,
• Noritaka Sekiya,
• Hiroaki Shimizu,
• Yuho Najima,
• Takeshi Kobayashi,
• Yuka Harada,
• Michinori Kohara,
• Noriko Doki

Affiliations

Takashi Toya

Hematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Tokyo Japan

Daichi Sadato

Clinical Research Support Center Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

Takahiro Sanada

Department of Microbiology and Cell Biology Tokyo Metropolitan Institute of Medical Science Tokyo Japan

Tomoko Honda

Department of Microbiology and Cell Biology Tokyo Metropolitan Institute of Medical Science Tokyo Japan

Yuya Atsuta

Hematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Tokyo Japan

Noritaka Sekiya

Department of Infection Prevention and Control Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

Hiroaki Shimizu

Hematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Tokyo Japan

Yuho Najima

Hematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Tokyo Japan

Takeshi Kobayashi

Hematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Tokyo Japan

Yuka Harada

Clinical Research Support Center Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

Michinori Kohara

Department of Microbiology and Cell Biology Tokyo Metropolitan Institute of Medical Science Tokyo Japan

Noriko Doki

Hematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Tokyo Japan